ONMDW OneMedNet Corp

Nasdaq Services-Commercial Physical & Biological Research DE CIK: 0001849380
AI RATING
STRONG_SELL
97% Confidence

Investment Thesis

OneMedNet faces an existential financial crisis with negative stockholders' equity of -$3.0M, indicating technical insolvency. The company burns $7.5M annually in operating cash while generating only $1.4M in flat revenue and $585K in cash reserves, providing less than one month of operational runway. Without immediate capital infusion or dramatic operational turnaround, the company faces imminent bankruptcy risk.

Strengths

  • + Net loss improved 72.3% year-over-year, demonstrating some cost control progress
  • + Manageable long-term debt of only $220K relative to total liabilities
  • + Maintains modest cash position of $585K as emergency buffer

Risks

  • ! Negative stockholders' equity of -$3.0M - company is technically insolvent
  • ! Critical liquidity crisis: current ratio of 0.43x cannot cover short-term obligations; <1 month cash runway at current burn rate
  • ! Revenue stagnation with negative gross margin (-37%) indicates fundamental business model failure - losing money on every transaction
  • ! Operating margin of -711% reflects severe structural unprofitability with no visible path to positive operations
  • ! Zero insider buying activity in 90 days signals management lacks confidence in turnaround

Key Metrics to Watch

Financial Metrics

Revenue
1.4M
Net Income
-2.8M
EPS (Diluted)
$-0.06
Free Cash Flow
-7.5M
Total Assets
2.2M
Cash
585.0K

Profitability Ratios

Gross Margin -37.0%
Operating Margin -711.3%
Net Margin -206.1%
ROE N/A
ROA -130.2%
FCF Margin -553.1%

Balance Sheet & Liquidity

Current Ratio
0.43x
Quick Ratio
0.43x
Debt/Equity
N/A
Debt/Assets
237.8%
Interest Coverage
-175.76x
Long-term Debt
220.0K
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings. It does not include stock price data and should not be considered financial advice. All fundamental data is sourced from SEC public domain filings. Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR | Analysis Date: 2026-04-13T17:09:21.687043 | Data as of: 2025-12-31 | Powered by Claude AI